• 1
    Hermansson A, Ketelhuth DF, Strodthoff D et al. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J Exp Med 2010; 207: 108193.
  • 2
    Jiang W, Swiggard WJ, Heufler C et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995; 375: 1515.
  • 3
    Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996; 86: 97383.
  • 4
    Medzhitov R, Preston-Hurlburt P, Janeway Jr CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 3947.
  • 5
    Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/Hej and C57BL/10ScCr Mice: mutations in TLr4 gene. Science 1998; 282: 20858.
  • 6
    Hoshino K, Takeuchi O, Kawai T et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 374952.
  • 7
    Qureshi ST, Lariviere L, Leveque G et al. Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4). J Exp Med 1999; 189: 61525.
  • 8
    Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11: 44351.
  • 9
    Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 7405.
  • 10
    Zuniga R, Lucchetti A, Galvan P et al. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol 2006; 80: 31225.
  • 11
    Edwards BH, Bansal A, Sabbaj S, Bakari J, Mulligan MJ, Goepfert PA. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol 2002; 76: 229822305.
  • 12
    Novitsky V, Gilbert P, Peter T et al. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol 2003; 77: 88290.
  • 13
    Ramduth D, Chetty P, Mngquandaniso NC et al. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses. J Infect Dis 2005; 192: 158896.
  • 14
    Kiepiela P, Ngumbela K, Thobakgale C et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13: 4653.
  • 15
    Geldmacher C, Currier JR, Herrmann E et al. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J Virol 2007; 81: 24408.
  • 16
    Liu J, O’Brien KL, Lynch DM et al. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 2009; 457: 8791.
  • 17
    Trumpfheller C, Finke JS, Lopez CB et al. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J Exp Med 2006; 203: 60717.
  • 18
    Salazar AM, Levy HB, Ondra S et al. Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study. Neurosurgery 1996; 38: 1096103.
  • 19
    Stahl-Hennig C, Eisenblatter M, Jasny E et al. Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques. PLoS pathog 2009; 5: e1000373.
  • 20
    Longhi MP, Trumpfheller C, Idoyaga J et al. Dendritic cells require a systemic type I interferon response to induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med 2009; 206: 1589602.
  • 21
    Trumpfheller C, Caskey M, Nchinda G et al. The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc Natl Acad Sci USA 2008; 105: 25749.
  • 22
    Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 2004; 199: 160718.
  • 23
    Pantel A, Cheong C, Dandamudi D et al. A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigento elicit Th1 T-cell immunity in vivo. Eur J Immunol 2011; doi: 10.1002/eji.201141855.
  • 24
    Bonifaz LC, Bonnyay DP, Charalambous A et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 2004; 199: 81524.
  • 25
    Bozzacco L, Trumpfheller C, Siegal FP et al. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci USA 2007; 104: 128994.
  • 26
    Idoyaga J, Lubkin A, Fiorese C et al. Comparable T helper 1 (Th1) and CD8 T-cell immnity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc Natl Acad Sci USA 2011; 108: 23849.
  • 27
    Dudziak D, Kamphorst AO, Heidkamp GF et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007; 315: 10711.
  • 28
    Soares H, Waechter H, Glaichenhaus N et al. A subset of dendritic cells induces CD4+ T cells to produce IFN-g by an IL-12-independent but CD70-dependent mechanism in vivo. J Exp Med 2007; 204: 1095106.
  • 29
    Pulendran B, Smith JL, Caspary G et al. Distinct dendritic cell subsets differentially regulate the class of immune responses in vivo. Proc Natl Acad Sci USA 1999; 96: 103641.
  • 30
    Maldonado-Lopez R, De Smedt T, Michel P et al. CD8a+ and CD8a- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 1999; 189: 58792.
  • 31
    Granelli-Piperno A, Pritsker A, Pack M et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J Immunol 2005; 175: 426573.
  • 32
    Cheong C, Choi JH, Vitale L et al. Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody. Blood 2010; 116: 382838.
  • 33
    Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194: 76980.
  • 34
    Flynn BJ, Kastenmuller K, Wille-Reece U et al. Immunization with HIV Gag targeted to dendritic cells followed by recombinant NYVAC induces robust T cell immunity in non human primates. Proc Natl Acad Sci USA 2011; 108: 71316.
  • 35
    Nchinda G, Amadu D, Trumpfheller C, Mizenina O, Uberla K, Steinman RM. Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells. Proc Natl Acad Sci USA 2010; 107: 42816.
  • 36
    Caskey M, Lefebvre F, Filali-Mouhim A et al. Synthetic double stranded RNA reliably induces innate immunity similar to a live viral vaccine in humans. J Exp Med 2011; 208: 235766.
  • 37
    Wang B, Kuroiwa JM, He LZ, Charalambous A, Keler T, Steinman RM. The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells. Ann N Y Acad Sci 2009; 1174: 617.
  • 38
    Sela U, Olds P, Park A, Schlesinger SJ, Steinman RM. Dendritic cells induce antigen-specific Treg that prevent graft vs. host disease and persist in mice. J Exp Med 2011; 208: 248996.